维普中文期刊产品整合服务
218篇 您的检索式:作者名="Cingolani"
    题名 作者 年代 出处 被引量
1Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history显示文摘BACKGROUND Nonalcoholic fatty liver disease(NAFLD)is a frequently reported condition in patients with inflammatory bowel disease(IBD).Both intestinal inflammation and metabolic factors are believed to contribute to the pathogenesis of IBDassociated NAFLD.AIM To evaluate the prevalence of steatosis and liver fibrosis(LF)in a cohort of IBD patients and the identification of metabolic-and IBD-related risk factors for NAFLD and LF.METHODS IBD patients were consecutively enrolled from December 2016 to January 2018.Demographic,anthropometric and biochemical data were collected so as eating habits.Abdominal ultrasound and transient elastography were performed to evaluate the presence of NAFLD and LF respectively.RESULTS A total of 178 consecutive patients were enrolled and included in the analysis(95 Ulcerative colitis,83 Crohn’s disease).NAFLD was detected by imaging in 72(40.4%)patients.Comparison between patients with and without NAFLD showed no significant differences in terms of IBD severity,disease duration,location/extension,use of IBD-related medications(i.e.,steroids,anti-TNFs,and immunomodulators)and surgery.NAFLD was significantly associated with the presence of metabolic syndrome[MetS;odds ratio(OR):4.13,P=0.001]and obesity defined by body mass index(OR:9.21,P=0.0002).IBD patients with NAFLD showed higher caloric intake and lipid consumption than those without NAFLD,regardless disease activity.At the multivariate analysis,male sex,advanced age and high lipid consumption were independent risk factors for the development of NAFLD.An increased liver stiffness was detected in 21 patients(16%)and the presence of MetS was the only relevant factor associated to LF(OR:3.40,P=0.01).CONCLUSION In this study,we demonstrate that risk factors for NAFLD and LF in the IBD population do not differ from those in the general population.Salvatore Magrì Danilo Paduano Fabio Chicco Arianna Cingolani Cristiana Farris Giovanna Delogu Francesca Tumbarello Mariantonia Lai Alessandro Melis Laura Casula Massimo C Fantini Paolo Usai 2019World Journal of Gastroenterology2019,25,37:8
2miRNA expression profile in human osteosarcoma: Role of miR-1 and miR-133bin proliferation and cell cycle control显示文摘Chiara Novello Laura Pazzaglia Chiara Cingolani Amalia Conti Irene Quattrini Maria Manara Mauro Tognon Piero Picci Maria Benassi 2013International Journal of Oncology2013,,2:2
3Age estimation in children by measurement of open apices in teeth 显示文摘Cameriere R Ferrante L Cingolani M 2006Int J Legal Med2006,120,1:1
4Plant functional traits,herbivore selectivity and response to sheep grazing in Patagonian steppe grasslands显示文摘Cingolani AM Posse G Collantes MB 0,,:1
5Increased systolic performance with diastolic dysfunction in adult spontaneously hypertensive rats显示文摘Cingolani OH Yang X-P Cavasin MA 2003Hypertension2003,41,:1
6Cardioprotective effect of beta-3adrenergic receptor agonism:role of neuronal nitric oxide synthase显示文摘Niu X Watts VL Cingolani OH 2012J Am Coll Cardiol2012,59,22:1
7查看详情显示文摘Anni M Manna L Cingolani R Valerini D. Cretí A.Lomascolo M 0,,18:1
8Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA) 显示文摘Cingolani A Antinori A Rizzo MG 2002AIDS2002,16,3:1
9Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure显示文摘Antinori A Zaccarelli M Cingolani A 2002AIDS Res Hum Retroviruses2002,18,12:1
10miRNA expression profile in human osteosarcoma:role of miR-1 and miR-133b in proliferation and cell cycle control显示文摘Novello C Pazzaglia L Cingolani C 2013Int J Oncol2013,42,:1
11Role of inducible nitric oxide synthase in cardiac function and remodeling in mice with heart failure due to myocardial infarction显示文摘Liu YH Carretero OA Cingolani OH 2005Am J Physiol2005,289,6:1
12Regression of hypertensive myocardial fibrosis by Na /H exchange inhibition显示文摘CINGOLANI H E REBOLLEDO 0 R PORTIANSKY E L 2003Hypertension2003,41,2:1
13Optimizing scale-up fermentation processes显示文摘Thiry M Cingolani D 2002TRENDS in Biotechnology2002,20,3:1
14Angiotensin II stimulates cardiac L-type Ca^2+ current by a Ca^2+ and protein kinase C-dependent mechanism 显示文摘AIELLO E A CINGOLANI H E 2001Am J Physiol Heart Circ Physiol2001,280,4:1
15Tailoring of nanocrystal sizes in CdSe films prepared by chemical deposition显示文摘TROJANEK F CINGOLANI R CANNOLETTA D 2000Journal of Crystal Growth2000,209,4:1
16Epstein-Barr virus infection is predictive of CNS involvement in systemic AIDS-related non-Hodgkin's lymphomas显示文摘Cingolani A Gastaldi R Fassone L 2000J Clin Oncol2000,18,19:1
17The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients: La Plata Study 显示文摘Cingolani H E Plastino J A Escudero E M 2006J Card Fail2006,12,7:1
18Reduction of cardiac fibrosis decreases systolic performance without affecting diastolic function in hypertensive rats显示文摘Cingolani OH Yang XP Liu YH 2004Hypertension2004,43,:1
19Circ Stretch-induced alkalinization of feline papillary muscle: An autocrine-paracrine system显示文摘Cingolani HE Alvarez BV 1998Circ Res1998,83,8:1
20Is stuning prevented by ischemic preconditioning显示文摘Mosca SM Gelpi RJ Milei J Fernandez AG Cingolani HE 1998Mol Cell Biochem1998,186,:1
返回顶部 每页显示:
共11页 首页 上一页 第1页 下一页 末页 /11 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费